Related references
Note: Only part of the references are listed.Influence of the formulation on the maximum tolerated doses of brain targeted nanoparticles of gallic acid by oral administration in Wistar rats
Kalpana Nagpal et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
In-vitro stability and metabolism of a tacrine-silibinin codrug
Katharina Zenger et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Nature as a source of metabolites with cholinesterase-inhibitory activity: an approach to Alzheimer's disease treatment
Brigida R. Pinho et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease
Eduardo Luis Konrath et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Pretreatment of SH-SY5Y cells with dicaffeoylquinic acids attenuates the reduced expression of nicotinic receptors, elevated level of oxidative stress and enhanced apoptosis caused by β-amyloid peptide
Jie Deng et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease
Jayasankar Kosaraju et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Berberis aetnensis and B-libanotica: a comparative study on the chemical composition, inhibitory effect on key enzymes linked to Alzheimer's disease and antioxidant activity
Marco Bonesi et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Implication of novel bis-imidazopyridines for management of Alzheimer's disease and establishment of its role on protein phosphatase 2A activity in brain
Kauntay D. Parekh et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Impact of caffeic acid on aluminium chloride-induced dementia in rats
Kafeel A. Khan et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Trehalose rescues Alzheimer's disease phenotypes in APP/PS1 transgenic mice
Jing Du et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)